Moderna’s shares soar after the company seeks FDA approval for the Covid-19 vaccine

TRIBUNNEWS.COM – Stock Modern surged to a record high on Monday (30/11/2020) after the biotechnology company confirmed final-stage testing of their coronavirus vaccine candidate was 94.1% effective.

Moderna (MRNA) is now planning to ask Food and Drug Administration (FDA) to approve the corona virus vaccine for emergency use.

Moderna will also ask regulators in Europe for conditional authorization, and continue a rolling review in other countries.

Most important, Modern said their coronavirus vaccine was 100% effective at blocking severe cases of Covid-19.

The news emerged when the number of Covid-19 cases in the US soared.

Also read: Comparison of the Covid-19 Vaccines from Moderna, Pfizer, and AstraZeneca / Oxford, which one is the best?

Also read: BUMN Minister Explains the Government’s Reasons for Not Choosing the Pfizher and Moderna Covid-19 Vaccines

The corona virus vaccine is deemed necessary to end the pandemic.

Reported by investors.com, on the stock market Monday, stocks Modern skyrocketed 20.2% to 152.74.

“We believe our vaccine will provide a new and powerful tool that can change the course of this pandemic and help prevent severe illness, hospitalizations and deaths,” Chief Executive Stephane Bancel said in a written statement.

–